A team led by investigators at Mass General Brigham and Dana-Farber Cancer Institute has developed and validated an artificial intelligence (AI)–based noninvasive tool that can predict the likelihood that a patient's oropharyngeal cancer-a type of head and neck cancer that develops in the throat-will spread, thereby signaling which patients should...
Mass General BrighamDec 23 2025 A team led by investigators at Mass General Brigham and Dana-Farber Cancer Institute has developed and validated an artificial intelligence –based noninvasive tool that can predict the likelihood that a patient's oropharyngeal cancer -a type of head and neck cancer that develops in the throat-will spread, thereby signaling which patients should receive aggressive treatment.
The research is published in Journal of Clinical Oncology. "Our tool may help identify which patients should receive multiple interventions or would be ideal candidates for clinical trials of intensive strategies such as immunotherapy or additional chemotherapy," said senior author Benjamin Kann, MD, of the Artificial Intelligence in Medicine Program at Mass General Brigham and a radiation oncologist at Dana-Farber Cancer Institute and Brigham and Women's Hospital."Our tool can also help identify which patients should undergo de-intensification of treatment, such as surgery alone." Treatments for oropharyngeal cancer, including combinations of surgery, radiation therapy, and chemotherapy, can be difficult to tolerate and may have lasting negative effects. Therefore, it's important to identify subgroups of patients who may benefit from less or more intensive treatment approaches. One way to accomplish this involves assessing whether the patient has pathologic extranodal extension , which occurs when cancer cells invade beyond the lymph node into surrounding tissue. Currently, ENE can only be definitively diagnosed by surgically removing and examining lymph nodes. To provide a method to assess ENE before treatment decisions are made, Kann and colleagues developed an AI-based tool that can take imaging data from computed tomography scans and predict the number of lymph nodes with ENE, an indicator of a patient's prognosis and likelihood of benefiting from intensified therapy. When the tool was applied to imaging scans from 1,733 patients with oropharyngeal carcinoma, the tool was able to predict uncontrolled cancer spread and worse patient survival. Integrating the AI's assessment into established clinical risk predictors improved risk stratification, leading to more accurate predictions of survival and cancer spread in individual patients. "The AI tool enables the prediction of number of lymph nodes with ENE, which could not be done before, and shows that it is a powerful, novel prognostic biomarker for oropharyngeal cancer that could be used to improve the current staging scheme and treatment planning," said Kann.Journal reference:Ye Z et al. "Automated Lymph Node and Extranodal Extension Assessment Improves Risk Stratification in Oropharyngeal Carcinoma" JCO DOI: 10.1200/JCO-24-02679
Head And Neck Cancer Neck Artificial Intelligence Carcinoma Chemotherapy Hospital Imaging Immunotherapy Lymph Node Lymph Nodes Medical School Medicine Oncology Oropharyngeal Cancer Radiation Therapy Research Surgery Therapy Throat
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Early identification of nutrition risk in ICU patients using artificial intelligenceA new study by researchers at the Icahn School of Medicine at Mount Sinai suggests that artificial intelligence (AI) could help predict which critically ill patients on ventilators are at risk of underfeeding,
Read more »
Guilty, the hate-filled Islamic State fanatics who plotted mass murder of Jews in ManchesterIt could have been ‘the deadliest terror attack’ in UK history had the operation not been thwarted, according to one of the country’s most senior counter terrorism officers
Read more »
LIVE updates as Islamic State fanatics who plotted mass murder of Jews in Manchester found GUILTYWalid Saadaoui and Amar Hussein denied the charges
Read more »
Why AI is a game-changer for faster, more targeted influenza vaccinesDiscover how artificial intelligence is transforming influenza vaccine development, accelerating timelines and improving targeting.
Read more »
Bondi policeman injured in mass shooting wakes from comaPC Scott Dyson had been in a medically-induced coma and undergoing surgery 'almost daily' but is now awake, his family said.
Read more »
Fears of 'mass exodus' of Jews after Islamic State fanatics convicted of terror plotMark Gardner, chief executive of the Community Security Trust (CST), spoke out after Walid Saadaoui, 38, of Crankwood Road, Abram, Wigan, and Amar Hussein, 52, of no fixed address, were convicted of plotting the mass murder of Jews in Manchester in the summer of 2024.
Read more »